MoneyWorks4Me

Amanta Healthcare - Quaterly Results

20 May 2026 Evaluate
The revenue for the March 2026 quarter is pegged at Rs. 769.95 millions, about 6.84% up against Rs. 720.63 millions recorded during the year-ago period.The Net Profit of the company registered a slight decline of -7.18% to Rs. 55.32  millions from Rs. 59.60 millions.A decline of 166.15 millions was observed in the OP in the quarter ended March 2026 from 191.26 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 769.95 720.63 6.84 2876.77 2747.08 4.72 2876.77 2747.08 4.72
Other Income 16.62 1.62 925.93 33.71 13.85 143.39 33.71 13.85 143.39
PBIDT 166.15 191.26 -13.13 632.28 610.53 3.56 632.28 610.53 3.56
Interest 42.46 62.81 -32.40 207.46 279.48 -25.77 207.46 279.48 -25.77
PBDT 123.69 128.45 -3.71 398.53 331.05 20.38 398.53 331.05 20.38
Depreciation 47.52 46.94 1.24 187.30 183.99 1.80 187.30 183.99 1.80
PBT 76.17 81.51 -6.55 211.23 147.06 43.64 211.23 147.06 43.64
TAX 20.85 21.91 -4.84 62.49 42.06 48.57 62.49 42.06 48.57
Deferred Tax -8.45 3.76 -324.73 -23.40 6.14 -481.11 -23.40 6.14 -481.11
PAT 55.32 59.60 -7.18 148.74 105.00 41.66 148.74 105.00 41.66
Equity 343.36 282.70 21.46 343.36 282.70 21.46 343.36 282.70 21.46
PBIDTM(%) 21.58 26.54 -18.69 21.98 22.22 -1.11 21.98 22.22 -1.11
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..